Kura Oncology, Inc.KURANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.27
↑ 58% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-7.84
Historical baseline
PeriodValueYoY Change
2025-3.27+24.2%
2024-4.31+37.5%
2023-6.90-12.7%
2022-6.12+14.0%
2021-7.12+63.2%
2020-19.34-111.7%
2019-9.13-11.8%
2018-8.17+18.5%
2017-10.03-150.6%
2016-4.00-